Back

The MADIT-ICD benefit risk score for Japanese patients -from Nippon Storm study-

31 August 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: Risk score for risk prediction in cardiovascular disease Scores ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Yukiko Takanashi

Chiba University Graduate School of Medicine, Chiba (Japan)

7 More presentations in this session

Presentation thumbnail
The incremetal predictive value of pulse wave velocity over score2 in the setting of primary cardiovascular prevention: a 6-year follow-up study
Doctor I. Ikonomidis (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Validation of digital cardiovascular risk score (DiCAVA) in the United States All of Us dataset
Doctor Z. Yao (Baltimore, US)
Abstract Slides Video
Presentation thumbnail
Refined selection of individuals for preventive cardiovascular disease treatment with a transformer-based risk model
Doctor S. Rao (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
A systematic review and meta-analysis on the predictive value of the C2HEST score to predict new onset atrial fibrillation in >11 million Western and Asian subjects.
Associate Professor D. Pastori (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Enhancing primary prevention: the incremental predictive value of NTproBNP beyond ASCVD risk assessment
Doctor J. Simoes De Azevedo Massa Pereira (Faro, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Risk score for risk prediction in cardiovascular disease

The Event

Event poster

ESC Congress 2024

31 August 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Development and validation of the MADIT-ICD benefit risk score for Japanese patients - from Nippon Storm study
thumbnail
Congress Presentation
Risk stratification for a primary prevention ICD: Performance of the MADIT-ICD Benefit Score in contemporary real world patients
thumbnail
Congress Presentation
Optimizing patient selection for cardiac resynchronization therapy in a multicenter study of Japanese patients: assessment of the MADIT-ICD benefit group

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources